Evaluating drug-drug interaction information in NDF-RT and DrugBank

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2041-1480

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Evaluating drug-drug interaction information in NDF-RT and DrugBank ; volume:6 ; number:1 ; day:11 ; month:5 ; year:2015 ; pages:1-10 ; date:12.2015
Journal of biomedical semantics ; 6, Heft 1 (11.5.2015), 1-10, 12.2015

Creator: Peters, Lee B.

Contributor: Bahr, Nathan
Bodenreider, Olivier
SpringerLink (Online service)

DOI: 10.1186/s13326-015-0018-0

URN: urn:nbn:de:101:1-2018070520414592052086

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Peters, Lee B.
Bahr, Nathan
Bodenreider, Olivier
SpringerLink (Online service)

Other Objects (12)

Case report: Medical cannabis—warfarin drug-drug interaction

Lurasidone drug-drug interaction studies: a comprehensive review

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies

Learning self-supervised molecular representations for drug–drug interaction prediction

Evaluation of a drug-drug interaction: fax alert intervention program

On the robustness of generalization of drug–drug interaction models

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels

Targeting continuity of care and polypharmacy to reduce drug–drug interaction

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin

A Review of Daclatasvir Drug–Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Lurasidone drug-drug interaction studies: a comprehensive review

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies

Learning self-supervised molecular representations for drug–drug interaction prediction

Evaluation of a drug-drug interaction: fax alert intervention program

On the robustness of generalization of drug–drug interaction models

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels

Targeting continuity of care and polypharmacy to reduce drug–drug interaction

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin

A Review of Daclatasvir Drug–Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Lurasidone drug-drug interaction studies: a comprehensive review

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies

Learning self-supervised molecular representations for drug–drug interaction prediction

Evaluation of a drug-drug interaction: fax alert intervention program

On the robustness of generalization of drug–drug interaction models

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels

Targeting continuity of care and polypharmacy to reduce drug–drug interaction

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin

A Review of Daclatasvir Drug–Drug Interactions

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Evaluating drug-drug interaction information in NDF-RT and DrugBank

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Case report: Medical cannabis—warfarin drug-drug interaction

Lurasidone drug-drug interaction studies: a comprehensive review

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies

Learning self-supervised molecular representations for drug–drug interaction prediction

Evaluation of a drug-drug interaction: fax alert intervention program

On the robustness of generalization of drug–drug interaction models

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels

Targeting continuity of care and polypharmacy to reduce drug–drug interaction

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin

A Review of Daclatasvir Drug–Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Lurasidone drug-drug interaction studies: a comprehensive review

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies

Learning self-supervised molecular representations for drug–drug interaction prediction

Evaluation of a drug-drug interaction: fax alert intervention program

On the robustness of generalization of drug–drug interaction models

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels

Targeting continuity of care and polypharmacy to reduce drug–drug interaction

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin

A Review of Daclatasvir Drug–Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Lurasidone drug-drug interaction studies: a comprehensive review

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies

Learning self-supervised molecular representations for drug–drug interaction prediction

Evaluation of a drug-drug interaction: fax alert intervention program

On the robustness of generalization of drug–drug interaction models

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels

Targeting continuity of care and polypharmacy to reduce drug–drug interaction

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin

A Review of Daclatasvir Drug–Drug Interactions

Related objects

Reset password